Listen: Nobels for science, biotech dealmaking, & a friendly FTC
What can we learn from mummy DNA? Is Pfizer single-handedly propping up biotech? And how do you get molecules to “click”?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. The newest Nobel laureates got their phone calls from Stockholm this week, and STAT science writer Megan Molteni joins us to explain their prize-winning work in medicine and chemistry. We also discuss the latest news in the life sciences, including the state of biotech dealmaking and the evolution of Amylyx Pharmaceuticals.
Read Original Article: Listen: Nobels for science, biotech dealmaking, & a friendly FTC »
